Differential effects of Doxorubicin and Actinomycin D on the stability of RNA binding proteins, RBM10 and RBM5: Actinomycin D promotes the nuclear speckles targeting of RBM10 and RBM5 through the novel structural elements

Abstract

AbstractBackgroundRNA binding motif (RBM) proteins, RBM10v1, RBM10v2 and RBM5 share a high degree of the conserved domains. So far, the drug-sensitivities of the RBMs in tumor cells have not been fully examined.ObjectiveThe expression profiles of RBM10 and RBM5 in several virus-transformed tumor cells, and the effect of the most established antitumor agents, actinomycin D and doxorubicin, were investigated.Methods and ResultsDoxorubicin and actinomycin D differentially reduced RBM10 and RBM5 protein, respectively in both of HeLa and COS-7 cells. RBM10 protein was highly sensitive to doxorubicin in HeLa, COS-7 and A549 cells. In silico analysis revealed the several sumoylation sites of RBM10 and its sumoylated form could be targeted for the activated ubiquitin proteasome system. Actinomycin D affected the nuclear speckles localization of RBM10 and RBM5 in COS-7 and A549 lung carcinoma cells. Addition of actinomycin D in the culture medium and following culture for 3〜4 hours promoted the prominent nuclear speckles of RBM10v2-GFP and RBM5. Hence, we explored the subnuclear localization of the full length RBM10v2 (852aa) and the amino terminally truncated forms and the responsible structural elements. The amino terminally truncated RBM10v2 [#486-852, #642-852], RBM10v2 [#648-852], RBM10v2 [#681-759, #681-852], and RBM10v2 [#660-852] retained the targeting elements for the nuclear speckles, nucleoplasm, nucleoli and whole nuclei, respectively.ConclusionRBM10 is highly sensitive to doxorubicin. Actinomycin D affects the structural elements of RBM10 and promotes the nuclear speckles targeting. The C-terminal regions: RBM10v2 [#642-647], [#642-659], and [#660-680] play critical roles in the targeting to the subnuclear compartments. SIM and sumoylation sits of RBM10 and PML4 are important for molecular interaction of RBM10 and PML.